Kimberly B. Dahlman
Vanderbilt University Medical Center(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Computational Drug Discovery Methods, Synthesis and biological activity, Cutaneous Melanoma Detection and Management, Cancer Genomics and Diagnostics
Most-Cited Works
- → RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)(2011)1,432 cited
- → Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy(2013)983 cited
- → Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance(2012)619 cited
- → Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance(2015)607 cited
- → FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR(2011)390 cited
- → Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction(2015)347 cited
- → Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides(2015)226 cited
- → Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials(2012)202 cited
- → BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors(2012)199 cited
- → Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers(2013)178 cited